Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salima Atis

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Methods in Cell Biology|January 25, 2025
Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testingClara Diaz Garcia-Prada, Salima Atis, Jean-Pierre Pouget, et al.
BMC Cancer|August 15, 2018
Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatmentDiego Tosi, Esther Pérez-Gracia, Salima Atis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2023
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide TherapyClara Diaz Garcia-Prada, Léna Carmes, Salima Atis, et al.
Journal for Immunotherapy of Cancer|March 26, 2025
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in miceAlexandra Fauvre, Chiara Ursino, Veronique Garambois, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Methods in Cell Biology|January 25, 2025
Development of an in vivo ovarian cancer peritoneal carcinomatosis model for radioimmunotherapy testingClara Diaz Garcia-Prada, Salima Atis, Jean-Pierre Pouget, et al.
BMC Cancer|August 15, 2018
Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatmentDiego Tosi, Esther Pérez-Gracia, Salima Atis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2023
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide TherapyClara Diaz Garcia-Prada, Léna Carmes, Salima Atis, et al.
Journal for Immunotherapy of Cancer|March 26, 2025
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in miceAlexandra Fauvre, Chiara Ursino, Veronique Garambois, et al.
Pageof 1